Want to join the conversation?
$CVS 2Q15 Q&A: Mushkin of Wolfe Research asked about thought process on Target. Larry replied that it expands the Company's reach in new geographies. It becomes an important solution to some of the challenges that CVS' health care system faces that today around access quality across geographies.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?